Skip to main content

Advertisement

Table 1 Baseline clinico-pathological characteristics (n = 102)

From: A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

Parameter N (%)
Age years (median, range) 69 (44–85)
Height 168 cm (152–186)
Weight 69.5 kg (45–175)
Gender
 Male 69 (68%)
 Female 33 (32%)
ECOG PS
 0 53 (52%)
 1 41 (40%)
 2 8 (8%)
Lung parenchyma metastasis
 Yes 68 (67%)
 No 34 (34%)
Lymph node metastasis
 Yes 72 (71%)
 No 30 (29%)
Loco-regional lymph node metastasis
 Yes 31 (30%)
 No 71 (70%)
Liver metastasis
 Yes 19 (19%)
 No 83 (81%)
Brain metastasis
 Yes 14 (14%)
 No 88 (86%)
Malignant pleural effusion
 Yes 9 (9%)
 No 93 (91%)
Bone metastasis
 Yes 27 (26%)
 No 75 (74%)
Adrenal gland metastasis
 Yes 11 (11%)
 No 91 (89%)
N. of metastatic sites
 1 21 (21%)
 2 34 (33%)
 3 47 (46%)